WallStSmart
RNAZ

Transcode Therapeutics Inc

NASDAQ: RNAZ · HEALTHCARE · BIOTECHNOLOGY

$8.01
-4.64% today

Updated 2026-04-30

Market cap
$7.75M
P/E ratio
P/S ratio
EPS (TTM)
$-52.59
Dividend yield
52W range
$6 – $22
Volume
0.0M

Transcode Therapeutics Inc (RNAZ) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
-200.0%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+98.7%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+7.2%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+11.8%
2025-11-14
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-25$-16.42$9.90$10.17+2.7%
2025-11-14$-5.82-470.6%$8.42$9.41+11.8%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-16.42
2025-09-30$-1.02$-5.82-470.6%
2025-06-30$-1.64$-5.13-212.8%
2025-03-31$-89.88$-1,286.15-1331.0%
2024-12-31$-89.88$-1,286.15-1331.0%
2024-09-30$-452.76$-147.84+67.3%
2024-06-30$-21,436.81$-27,350.42-27.6%
2024-03-31$-10.80$-22.84-111.5%$753146.00
2023-12-31$-356.40$-627.33-76.0%
2023-09-30$-1.50$-1.68-12.0%
2023-06-30$-3.39$-3.29+2.9%
2023-03-31$-0.38$-0.38+0.0%

Frequently asked questions

Has Transcode Therapeutics Inc beaten earnings estimates?
Transcode Therapeutics Inc has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports, with an average EPS surprise of -200.0% over the last 3 quarters.
How does RNAZ stock react to earnings?
RNAZ stock has moved an average of +7.2% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.